Clinical Trials on Citrullinemia Type I

Total 56774 results

Nationwide Children's Hospital

Terminated

Impaired Family Dynamics Leads to Non Compliance in Type I Diabetes

Type 1 Diabetes

United States
IRCCS San Raffaele
Fondazione Telethon

Active, not recruiting

Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant (TigetT10_MPSIH)

Mucopolysaccharidosis IH

Italy
Ruhr University of Bochum

Unknown

Effects of Repetitive Electric Sensory Stimulation (RSS) as Intervention in Complex-regional-pain-syndrome Type I (CRPS)

Complex Regional Pain Syndrome Type I of the Upper Limb

Germany
M-DT1
Assistance Publique Hopitaux De Marseille; Centre Hospitalier Intercommunal...

Completed

Type 1 Diabetic Post Prandial Glycemia Evaluation Using an Algorithm (EGHYA)

Type I Diabetes

France
University of Alberta
Sernova Corp

Terminated

A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation

Type I Diabetes

Canada
Wockhardt

Withdrawn

Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics

Type I Diabetes
University of Groningen

Withdrawn

Single-port Thoracoscopic Sympathicotomy in Complex Regional Pain Syndrome Type I (CRPS)

Complex Regional Pain Syndrome Type I of the Upper Limb

Netherlands
AstraZeneca
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes

Diabetes Mellitus

United States
University of Zurich
Balgrist University Hospital

Recruiting

Embodied Virtual Reality for Chronic Pain

Complex Regional Pain Syndrome I (CRPS I) | Complex Regional Pain Syndromes | Osteoarthritis Hand | Complex Regional Pain Syndrome Type II | Complex Regional Pain Syndrome Type I of the Upper Limb | Complex Regional Pain Syndrome I of Upper Limb | Complex Regional Pain Syndrome II of Upper Limb | Peripheral Nerve Injury Upper Limb and other conditions

Switzerland
Cairo University

Unknown

Clinical Evaluation of Glass Ionomer With Glass Hybrid Technology Versus Conventional High Viscosity Glass Ionomer in Class I Cavities of High Caries Risk Patients

Class I Cavities in High Caries Risk

Egypt
Ankara Diskapi Training and Research Hospital

Completed

Comparison of I-Gel Laryngeal Mask Airway Placement Methods in Elective Surgery

Effective I -Gel Mask Airway Placement Technique

Turkey
Cairo University

Unknown

Friction Versus Frictionless Mechanics During Maxillary En-masse Retraction in Adult Patients

En-masse Retraction , Class I Bimaxillary Protrusion
Northwestern University
University of Illinois at Chicago

Completed

A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use

Diabetes Mellitus Type II | Diabetes Mellitus Type I

United States
National Institute of Diabetes and Digestive and...
Novo Nordisk A/S

Active, not recruiting

A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 (TOPPLE T1D)

Type I Diabetes

United States
Wockhardt

Terminated

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

Type I Diabetes

United States, India
Wockhardt

Withdrawn

Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients

Type I Diabetes
Scripps Translational Science Institute

Withdrawn

Epigenetic Modifications of Diabetes Mellitus Type I

Type I Diabetes

United States
Pharvaris Netherlands B.V.

Completed

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema (RAPIDe-1)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditions

Bulgaria, United States, Spain, Israel, Germany, Canada, Czechia, France, Hungary, Italy, Netherlands, Poland, United Kingdom
CENTOGENE GmbH Rostock

Completed

Biomarker for Hereditary AngioEdema Disease (BioHAE)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | C1 Esterase Inhibitor Deficiency | HAE | Angio Edema | C4 Deficiency | Hereditary Angioedema Type III

Turkey, Armenia, Georgia, India, Peru, Poland, Romania
Medtronic Diabetes R&D Denmark

Unknown

Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4

Diabetes Mellitus Type II | Diabetes Mellitus Type I

Denmark
Eclypia

Recruiting

SKAMo-2: the Real-life Test of Continuous Photoacoustic Signal by Neogly in Patients With Type I Diabetes

Diabetes

France
University of Alabama at Birmingham
Juvenile Diabetes Research Foundation; Janssen Pharmaceuticals; NOW Foods; Diamyd...

Completed

The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes (GABA)

Type I Diabetes

United States
ARAIR Assistance

Terminated

Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump (AAHPI)

Type I Diabetes

France
Jaeb Center for Health Research
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I Diabetes

Diabetes Mellitus, Type I

United States
Legacy Health System
Juvenile Diabetes Research Foundation

Completed

Artificial Pancreas Control System in an Inpatient Setting

Type I Diabetes Mellitus

United States
Oshadi Drug Administration

Completed

Safety and Efficacy of Single Administration of Oshadi Oral Insulin in Type I Diabetes Patients

Diabetes

Israel
Seattle Children's Hospital
Medtronic; The Gerber Foundation

Unknown

The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children (Gerber RTSA)

Diabetes Mellitus, Type I

United States
Sanofi

Completed

Dose-Exposure-Response in Type 1 Diabetes Mellitus

Diabetes Mellitus, Type I

Germany
Pharvaris Netherlands B.V.

Active, not recruiting

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II (HAE CHAPTER-1)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditions

United States, Poland, Germany, Austria, Bulgaria, Canada, Ireland, Italy, United Kingdom
Sanofi

Completed

Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL (TOP1)

Type I Diabetes Mellitus

Brazil
Texas Tech University Health Sciences Center

Completed

Mental Health Screenings in Adolescents With Type I Diabetes

Diabetes Mellitus Type I

United States
Yale University

Completed

A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes

Type I Diabetes

United States
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus

Type I Diabetes Mellitus

Russian Federation
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Hurler Disease (BioHurler) (BioHurler)

Metabolism, Inborn Errors | Mucopolysaccharidosis Type I | Gargoylism

Germany, India, Sri Lanka, Egypt
University of Minnesota
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

MRS to Determine Neuroinflammation and Oxidative Stress in MPS I

Mucopolysaccharidosis Type I

United States
Johns Hopkins Bloomberg School of Public Health
Massachusetts General Hospital; Mayo Clinic; National Institute of Diabetes and... and other collaborators

Not yet recruiting

Gastroparesis Registry 4 (GpR4)

Gastroparesis | Gastro-Intestinal Disorder | Gastroparesis Due to Diabetes Mellitus Type I | Gastroparesis Nondiabetic | Gastroparesis Due to Diabetes Mellitus Type II | Functional Disorder of Gastrointestinal Tract

United States
Sheba Medical Center

Unknown

Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers

Type I Diabetes Mellitus With Ulcer | Type II Diabetes Mellitus With Ulcer

Israel
Hospital Mutua de Terrassa

Recruiting

Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control (OPTIM@TE)

Diabetes Mellitus, Type I

Spain
Rodolfo Alejandro
University of Miami; National Institutes of Health (NIH); Health Resources and... and other collaborators

Active, not recruiting

Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression

Diabetes Mellitus, Type I

United States
City of Hope Medical Center
National Institutes of Health (NIH)

Active, not recruiting

Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen

Diabetes Mellitus

United States
University of Colorado, Denver
DexCom, Inc.

Completed

Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy

Diabetes Mellitus, Type I

United States
Massachusetts General Hospital
Boston Area Diabetes Endocrinology Research Center (funded by NIDDK)

Completed

Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients

Diabetes Mellitus, Type I

United States
Medical University of Vienna

Completed

Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects

Type I Diabetes

Austria
Yale University

Completed

Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs (PK/PD)

Diabetes Mellitus, Type I
EarlySense Ltd.
Schneider Children's Medical Center, Israel

Withdrawn

Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device

Type I Diabetes

Israel
MP Biomedicals, LLC
MP Biomedicals Asia Pacific Pte. Ltd.

Completed

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

HTLV-I Infections | HTLV-II Infections | Human T-lymphotropic Virus 1 | Human T-lymphotropic Virus 2 | HTLV I Associated T Cell Leukemia Lymphoma | HTLV I Associated Myelopathies

United States
MP Biomedicals, LLC
Vital Systems Inc.

Unknown

Evaluation of the MP Diagnostics HTLV Blot 2.4

HTLV-I Infections | HTLV-II Infections | Human T-lymphotropic Virus 1 | Human T-lymphotropic Virus 2 | HTLV I Associated T Cell Leukemia Lymphoma | HTLV I Associated Myelopathies

United States
Sanofi

Active, not recruiting

Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3 (ELIKIDS)

Gaucher's Disease Type III | Gaucher's Disease Type I

Canada, Argentina, France, Italy, Japan, Russian Federation, Spain, Sweden, Turkey, United Kingdom
MP Biomedicals, LLC
MP Biomedicals Asia Pacific Pte. Ltd.

Completed

Dual Algorithm Post Market Clinical Study

HTLV-I Infections | HTLV-II Infections | Human T-lymphotropic Virus 1 | Human T-lymphotropic Virus 2 | HTLV I Associated T Cell Leukemia Lymphoma | HTLV I Associated Myelopathies

United States
Nationwide Children's Hospital

Withdrawn

Insulin Resistance in Type I Diabetes in Pediatric Care

Type 1 Diabetes

United States

Clinical Trials on Citrullinemia Type I

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations